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Dectin-1/CLEC7A is a pattern recognition receptor that recognizes β-1,3 glucans, and
its stimulation initiates signaling events characterized by the production of inflammatory
cytokines from human dendritic cells (DCs) required for antifungal immunity. β-glucans
differ greatly in size, structure, and ability to activate effector immune responses from
DC; as such, small particulate β-glucans are thought to be poor activators of innate
immunity. We show that β-glucan particle size is a critical factor contributing to the secretion of cytokines from human DC; large β-glucan-stimulated DC generate significantly
more IL-1β, IL-6, and IL-23 compared to those stimulated with the smaller β-glucans.
In marked contrast, the secretion of TSLP and CCL22 were found to be insensitive to
β-glucan particle size. Furthermore, we show that the capacity to induce phagocytosis,
and the relative IL-1β production determined by β-glucan size, regulates the composition
of the cytokine milieu generated from DC. This suggests that β-glucan particle size is
critically important in orchestrating the nature of the immune response to fungi.
Keywords: dectin-1, β-glucan, IL-1β, dendritic cell, reactive oxygen species, phagocytosis

INTRODUCTION
Pattern recognition receptor (PRR) signaling pathways are a critical component of innate host
defense against infectious pathogens. Human dectin-1/CLEC7A is a PRR of the C-type lectin family
of receptors, predominantly expressed on myeloid-derived cells (1, 2), and recognizes exposed β-1,3
glucans (β-glucans) present on fungi and bacteria cell walls (3). Engagement of dectin-1 stimulates
activation of its unconventional immunoreceptor tyrosine activation motif (hemITAM) (3–6),
followed by subsequent activation of downstream Syk-dependent and -independent signaling
events (5, 7, 8). The engagement of dectin-1 signaling has been reported to initiate a plethora of
immunological defense mechanisms including phagocytosis (2, 9, 10), reactive oxygen species
(ROS) production (6, 8), inflammasome complex activation (8, 11–13), and the release of inflammatory cytokines (7, 14–16), required for antifungal immunity.
β-Glucan molecules exhibit heterogeneity in size, structure, and capacity to activate immunological effector responses (10, 14, 15, 17, 18). Functional dectin-1 signaling requires the β-glucan to be
particulate, or in an immobilized form (18), and the size and structure of the β-glucan particulate
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We report here that the size of β-glucan particles regulates the
production of certain cytokines (IL-1β, IL-6, and IL-23), while
others (TSLP and CCL22) were unaffected by β-glucan size.
Furthermore, we show that the regulation of IL-1β production
and phagocytosis, both determined by β-glucan size, provides a
key molecular checkpoint in eliciting appropriate cytokine secretion from mDC in response to dectin-1 activation.

is key to dictating the magnitude of the inflammatory immune
response initiated by dendritic cells (DCs) in response to
stimulation (14, 15, 17). It has been suggested that β-glucan size
controls the capacity of myeloid-derived cells to phagocytose
fungal products. Therefore, dectin-1-mediated phagocytosis is
thought to attenuate the production of inflammatory cytokines
from DC (14, 15), with small particulate β-glucans deemed poor
activators of innate immunity. Furthermore, fungal species such
as Candida albicans (C. albicans) exist as both colonizing yeast
and invasive hyphae, and structural differences exist in β-glucans
derived from these differing forms—hyphae exhibit a cyclical
β-glucan structure while yeast β-glucans are linear (17). These
structural differences have been shown to modulate the production of the inflammatory cytokine IL-1β (17) and alter the rate
of phagocytosis (10), with small β-glucan particulates inducing
rapid phagocytosis and limited IL-1β. It is well established that
the production of IL-1β along with IL-6 and IL-23 are required
for antifungal immunity in part by priming the adaptive immune
response to induce the differentiation of CD4+ T cells to TH1/
TH17 cells (3, 12, 16, 19). Therefore, the aim of this study was to
further investigate how β-glucan size controls dectin-1-mediated
responses in primary human monocyte-derived dendritic cells
(mDCs). Patients with chronic granulomatous disease (CGD) are
unable to generate nicotinamide adenine dinucleotide phosphateoxidase (NADPH)-derived ROS. As a result, they have reduced
antifungal killing activity and suffer from recurrent fungal infections (20–22). Therefore, a better understanding of how β-glucan
size regulates key antifungal mechanisms, including the need for
ROS, could lead to improved management of infection.

RESULTS
β-Glucan Particle Size Differentially
Affects Cytokine Secretion in Human mDC

It has been previously shown that β-glucan particle size significantly
affects inflammatory cytokine secretion from myeloid-derived
cells with smaller particulate forms of β-glucan found to be weak
inducers of cytokine responses. This study aimed to characterize
further the differences in cytokine responses elicited by either the
large particulate β-glucan, curdlan (up to 0.2 mm diameter), or
β-glucan-microparticles (glucan-mp; 1–5 µm diameter) (14), in
human mDC by measuring IL-1β, IL-6, IL-23, TSLP, and CCL22
secretion in response to these different stimuli. Characterization of
both curdlan and glucan-mp by high field 1H-NMR showed these
β-glucans to have very similar primary structures (Supplementary
Image 1). mDC stimulated with curdlan produced large amounts
of IL-1β, IL-6, and IL-23, as compared to glucan-mp stimulated
mDC secreted much reduced, though still detectable, quantities
of IL-1β, IL-6, and IL-23 (Figures 1A–C). In marked contrast,
curdlan- and glucan-mp induced secretion of similar quantities
of TSLP and CCL22 (Figures 1D,E). However, since curdlan

Figure 1 | β-Glucan particle size differentially affects cytokine secretion by human monocyte-derived dendritic cell (mDC). (A–E) Human mDCs were stimulated
with curdlan or β-glucan-microparticles (glucan-mp) for 24 h (n = 8 donors), and with curdlan or curdlan-microparticles (curdlan-mp) (n = 7 donors) (F–J) and IL-1β,
IL-6, IL-23, TSLP, and CCL22 measured by enzyme-linked immunosorbent assay. Cumulative data displayed as mean ±SEM.
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and the glucan-mp were derived from different microorganisms,
A. faecalis (a Gram-negative bacterium) and the yeast S. cerevisiae,
respectively, we wished to ensure that the findings were not due
to differences in the species from which they were prepared.

Therefore, we produced curdlan microparticles (curdlan-mp),
using a previously described sonication protocol (14). Once more,
we observed much reduced amounts of IL-1β, IL-6, and IL-23 in
response to curdlan-mp as compared to curdlan, but no difference
in TSLP or CCL22 (Figures 1F–J). Additionally, mDC stimulated
with curdlan-or glucan-mp displayed no difference in activation
status, as similar levels of surface expression of CD11c, CD86,
and HLA-DR were observed (Figure 2). Thus, the results were
consistent with a difference in the size of the different β-glucan
preparations affecting cytokine production. To examine whether
the effects observed were due to differences in gene transcription,
we also tested whether particle size resulted in similar differences in
cytokine gene transcription and found that IL-1β, IL-6, IL-23p19,
and TSLP mRNA expression mirrored the data on secretion of each
cytokine (Figures 3A–H). Thus, small particles induce reduced
inflammatory gene transcription compared to larger particles.

The Quantity of IL-1β Stimulated by a
β-Glucan Particle Is a Key Factor That
Determines the Secretion of Other
Cytokines by mDC

Figure 2 | β-Glucan particle size does not affect activation status of human
monocyte-derived dendritic cell (mDC). Human mDCs were stimulated with
either curdlan or glucan-mp for 24 h and CD11c, CD86, and HLA-DR
expression measured to determine mDC activation by flow cytometry (n = 2
donors). Gray-filled profile represents unstimulated unstained mDC, the red
line represents unstimulated stained mDC, the blue line represents
curdlan-stimulated stained mDC, the green line represents glucan-mpstimulated stained mDC.

Our data suggested that small particulate β-glucans are not
invariably poor inducers of cytokine secretion, but that certain
cytokines are more sensitive to the size of the β-glucan particle
used. Previous work has highlighted the importance of IL-1β
secretion in orchestrating dectin-1-mediated immune responses
(12, 16, 23). Therefore, we examined whether the amount of

Figure 3 | IL-1β, IL-6, IL-23p19, and TSLP mRNA expression by monocyte-derived dendritic cell (mDC) in response to curdlan or β-glucan-microparticles reflects
cytokine production. (A–H) Human mDCs were stimulated with either curdlan or glucan-mp for 4, 8, or 12 h (n = 2 donors). IL-1β, IL-6, IL-23p19, and TSLP mRNA
expression were measured by quantitative real-time polymerase chain reaction as relative expression (2−ΔCt), using HPRT expression as a housekeeping gene. Data
points presented as the mean of replicate values.
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IL-1β stimulated by β-glucan particles of different sizes is critical
in determining the amounts of other cytokines produced. We
showed that pro-IL-1β protein expression in response to glucanmp-stimulation was markedly reduced compared to curdlan
stimulation (Figure 4A). Furthermore, exogenous recombinant
IL-1β added at similar concentrations to that produced by curdlan stimulation recovered glucan-mp IL-6 and IL-23 secretion
to levels equivalent to those produced with curdlan stimulation
(Figures 4B,C). In contrast, amounts of CCL22 secreted were
unaffected by addition of exogenous IL-1β (Figure 4E), while
TSLP secretion was augmented, but only approximately twofold
(Figure 4D), as compared to the >10-fold increase seen for IL-6

and IL-23. This result is in agreement with our previous finding
that there is a requirement for signaling through the IL-1 receptor
for optimal TSLP production (23). However, it is clear that unlike
with IL-6 and IL-23, the additional IL-1β generated with curdlan
stimulation of mDC is not essential for TSLP expression as the
relatively low amounts of IL-1β produced in response to glucanmp are sufficient for substantial secretion of TSLP.

NADPH Oxidase-Derived ROS Are
Required for IL-1β Secretion from mDC
Stimulated with Glucan-mp, but Not with
Curdlan

Since the amounts of IL-1β produced by mDC in response to large
and small β-glucan particles differed substantially, we wished to
examine the signaling requirements for the IL-1β production by
each form of β-glucan. There are numerous reports showing the
importance of generation of ROS, and the induction of hypoxiainducible factor 1-alpha (HIF-1α), to induce the changes in cellular metabolism required for IL-1β expression during stimulation
through dectin-1 (6, 8, 24, 25). We showed that curdlan and
glucan-mp induced similar quantities of ROS in mDC
(Figure 5A). They also both induced HIF-1α expression, though
this was more marked with curdlan (Figure 5B). To determine
the contribution of NADPH-derived ROS (termed ROS from
this point) to HIF-1α expression and the induction of IL-1β, we
generated mDC from patients with CGD; these patients have
mutations in genes encoding components of the NADPH oxidase
complex and, therefore, cannot generate ROS. When mDC from
CGD patients were stimulated with glucan-mp, neither HIF-1α,
nor pro-IL-1β were detected (Figure 5B), indicating that both
required NADPH oxidase activity and likely ROS production. In
contrast, curdlan stimulation induced pro-IL-1β in mDC from
CGD patients, although this was reduced compared to healthy
controls, and HIF-1α was not detected, thus indicating a ROS/
HIF-1α-independent mechanism of pro-IL-1β production.
Accordingly, IL-1β, IL-6, IL-23, and TSLP secretion was effectively
abolished in mDC from CGD patients responding to glucan-mp,
but not significantly affected when the same cells responded to
curdlan (Figures 5C–L). As expected from the findings reported
above, normal levels of IL-6 (Figure 5I), IL-23 (Figure 5J), and
near normal levels of TSLP (Figure 5K) were produced by mDC
from CGD patients responding to curdlan, since sufficient IL-1β
was produced even in the absence of ROS and HIF-1α induction.
Both curdlan and glucan-mp-induced CCL22 were insensitive to
ROS production (Figures 5G,L), with a suggestion of enhanced
levels from CGD patients. Thus, these experiments showed that
IL-1β production in response to curdlan proceeds in the absence
of ROS (and of HIF-1α), whereas this does not occur when
glucan-mp are used to stimulate mDC.
Figure 4 | IL-1β concentration regulates glucan-mp-induced IL-6, IL-23,
and TSLP secretion in monocyte-derived dendritic cell (mDC). (A) Human
mDCs were stimulated with curdlan or glucan-mp for 8 h and pro-IL-1β
protein expression measured by immunoblot (representative experiment
presented; one of three). (B–E) Human mDC stimulated with glucan-mp and
recombinant IL-1β simultaneously for 24 h (n = 6 donors). IL-6, IL-23, TSLP,
and CCL22 were measured by enzyme-linked immunosorbent assay, with
cumulative data displayed as mean ± SEM.
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Inhibition of β-Glucan Internalization
Allows IL-1β to Be Produced and Only
Partially Requires NADPH OxidaseDerived ROS

As β-glucan size affected the production of IL-1β, and the
requirement for NADPH oxidase activity to produce IL-1β, we
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Figure 5 | β-Glucan size affects the requirement for reactive oxygen species (ROS) in IL-1β induction. (A) Human monocyte-derived dendritic cell (mDC) stimulated
with curdlan or glucan-mp for 8 h. ROS were detected by incubating cells with CellRox Green fluorescence dye and analysis by flow cytometry (representative
experiment of two) presented, (B) Human mDCs from healthy donors or chronic granulomatous disease (CGD) patients were stimulated with curdlan or glucan-mp
for 8 h. HIF-1α and pro-IL-1β protein expression measured by immunoblot (n = 2 donors). (C–L) Human mDC from healthy donors or CGD patients were stimulated
with curdlan or glucan-mp for 24 h (n = 6 donors). IL-1β, IL-6, IL-23, TSLP, and CCL22 secretion were measured by enzyme-linked immunosorbent assay, with
cumulative data displayed as mean ± SEM.

investigated the mechanism accounting for the effects of particle
size. The size of β-glucan particles affects the capacity of murine
myeloid-derived cells to phagocytose them and induce inflammatory cytokines (14, 15). Thus, we treated human mDC with
cytochalasin D (CYTD) to prevent glucan-mp internalization
by phagocytosis and found that this substantially increased
the amounts of IL-1β, IL-6, and IL-23 produced in response to
glucan-mp, to levels equivalent to those obtained with curdlan
stimulation; there was a less marked but significant increase in
TSLP production, but no effect on CCL22 secretion since this
was already maximal with glucan-mp (Figures 6A–E). Therefore,
the inhibition of phagocytosis of glucan-mp had the same effect
as the supplementation of glucan-mp-stimulated mDC cultures
with exogenous IL-1β. The enhancement of glucan-mp-induced

Frontiers in Immunology | www.frontiersin.org

cytokine production by CYTD was independent of NADPH oxidase activity and likely ROS production, since mDC from CGD
patients also produced augmented amounts of these cytokines
when treated with CYTD (Figures 6F–I). Lack of NADPH oxidase activity had no effect on CCL22 secretion (Figure 6J). To
further confirm whether these differences were a result of dectin1-mediated phagocytosis, we examined the relative capacity of
curdlan and glucan-mp to induce a decrease in dectin-1 surface
expression on mDC. Glucan-mp-stimulated mDC induced a
rapid decrease in surface dectin-1 expression 30 min poststimulation, whereas expression on mDC during curdlan stimulation
barely changed in comparison to unstimulated stained controls,
and this expression was maintained 4 h post-curdlan stimulation
(Figure 7). Moreover, CYTD pretreatment of mDC stimulated
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Figure 6 | Treatment with cytochalasin D (CYTD) enhances IL-1β induction by monocyte-derived dendritic cell (mDC) from both healthy donors and chronic
granulomatous disease (CGD) patients stimulated with glucan-mp. (A–E) Human mDCs were preincubated with CYTD for 1 h and then stimulated with glucan-mp
for 24 h (n = 6 donors). (F–J) Human mDCs derived from CGD patients were preincubated with CYTD for 1 h and then stimulated with glucan-mp for 24 h (n = 3
donors). IL-1β, IL-6, IL-23, TSLP, and CCL22 were measured by enzyme-linked immunosorbent assay.

with glucan-mp inhibited dectin-1 internalization (Figure 7) and
likely prolonged signaling through dectin-1.
It is well established that dectin-1 signaling promotes the differentiation of CD4+ T cells to TH1- and TH17-cells (3, 16, 26, 27);
however, as β-glucan size significantly affected cytokine secretion
from mDC, we investigated whether this had an impact on CD4+
T cell differentiation. CD3/CD28-stimulated naïve CD4+ T cells
were cultured in supernatants derived from mDC prestimulated
with either curdlan or glucan-mp. CD4+ T cells cultured in conditioned media derived from curdlan-stimulated mDC produced
significantly higher levels of IL-17 and IFNγ compared to those
CD4+ T cells cultured in conditioned media from glucan-mp
stimulated mDC (Figures 8A,B). This increased production of
IL-17 and IFNγ observed in curdlan-treated cells could be replicated when glucan-mp-stimulated mDCs were supplemented
with recombinant IL-1β (Figures 8C,D).
Together these data show that failure to phagocytose β-glucan
containing particles, as occurs with curdlan, or with glucan-mp
in cells treated with CYTD, allows the production of IL-1β in a
manner independent of NADPH oxidase activity. However, when
phagocytosis of glucan-mp proceeds normally, the small amounts
of IL-1β secreted requires NADPH activity, and is, therefore, regulated by an alternative mechanism compared to larger β-glucan
particles that are not internalized. Therefore, the small amounts
of IL-1β produced in response to internalized glucan-mp are
insufficient to allow production of substantial amounts of IL-6 or

Frontiers in Immunology | www.frontiersin.org

IL-23 and this is the mechanism by which reduced inflammatory
responses to glucan-mp occur. Furthermore, the differences in
cytokine milieu generated as a result of β-glucan size modify the
capacity to drive TH1- and TH17-cell differentiation.

DISCUSSION
To examine cytokine secretion induced in human mDC through
dectin-1, we utilized β-glucans of differing size: curdlan (large
particulate) and glucan-mp (small particulate). Similar to previous studies in mice (14, 15), we showed that curdlan-stimulated
human mDC generated significantly more IL-1β, IL-6, and
IL-23 compared to those stimulated with the smaller glucan-mp,
and these results reflected particle size since curdlan prepared
as a small particulate also produced much lower levels of these
cytokines. In marked contrast, secretion of TSLP and CCL22, factors associated with TH2 immune responses, were generally unaffected by β-glucan particle size. Importantly, β-glucan particle
size had little effect on mDC activation status; thus, while small
β-glucans such as glucan-mp have previously been deemed (from
murine studies) to be weak inducers of innate immune responses
(14, 15), our data show that this conclusion cannot be generalized
to all cytokines and chemokines. We suggest that small β-glucan
particles will effectively stimulate human TH2 immune responses
while not favoring more pro-inflammatory responses, including
TH17 responses, which require IL-6 and IL-23.
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Figure 7 | β-Glucan particle size affects surface dectin-1 expression on
human monocyte-derived dendritic cell (mDC). Human mDC stimulated with
either curdlan, glucan-mp, or glucan-mp subsequent to cytochalasin D
(CYTD) pretreatment, for 30 min or 4 h (n = 2 donors). Dectin-1 expression
following stimulation was determined relative to unstimulated stained mDC by
flow cytometry. Gray-filled profile represents unstimulated unstained mDC,
the red line represents unstimulated stained mDC, the blue line represents
curdlan stimulated stained mDC, the green line represents glucan-mp
stimulated stained mDC, and the orange line represents glucan-mp
stimulated stained mDC subsequent to CYTD pretreatment (note that the
red, blue, and orange lines essentially overlie each other).

Figure 8 | Naïve CD4+ T cells produce higher amounts of IL-17 and IFNγ
when stimulated in conditioned media derived from curdlan-stimulated
compared to glucan-mp-stimulated monocyte-derived dendritic cell (mDC).
(A–D) CD3/CD28-stimulated naïve CD4+ T cells were cultured in
supernatants derived from mDC prestimulated with either curdlan,
glucan-mp, or glucan-mp supplemented with recombinant IL-1β
simultaneously for 7 days (n = 4 donors). IL-17 and IFNγ measured by
enzyme-linked immunosorbent assay. Cumulative data displayed as
mean ± SEM.

The different cytokine profiles seen with large and small
β-glucan particles were shown to be a reflection of the different
abilities of these stimuli to induce IL-1β. IL-6, and IL-23 required
the large amounts of IL-1β produced in response to curdlan
whereas TSLP, while still, as we have previously shown (23, 28),
requiring IL-1β for its secretion, was produced in substantial
quantities even in the presence of the small amounts of IL-1β generated from glucan-mp-stimulated mDC. This suggests that the
threshold concentration of IL-1β required for TSLP production is
very low, and much lower than that required for IL-6 and IL-23.
Given the critical difference in the induction of IL-1β by the
different sized particles, we investigated the mechanism underlying this and showed that phagocytosis was critical. The small
particulate glucan-mp are phagocytosed readily (14), resulting in
loss of surface expression of dectin-1. Conversely large particles
are not phagocytosed, and surface dectin-1 expression is maintained. By preventing phagocytosis of glucan-mp with CYTD, we
inhibited dectin-1 downregulation, completely restored their ability to induce IL-1β, and hence other cytokines, to the same levels
as found with curdlan stimulation. We speculate that continued
surface expression of dectin-1 allows prolonged stimulation
through the receptor, and hence enhanced production of IL-1β.
Our data are consistent with Rosas et al. concept that curdlan’s
capacity to induce elevated inflammatory cytokine expression is

Frontiers in Immunology | www.frontiersin.org

due to “frustrated phagocytosis” (14), and with the idea that this
would result in curdlan maintaining dectin-1 expression on the
cell surface (15).
In relation to the effects of preventing phagocytosis, we
also noted that induction of IL-1β under these conditions was
independent of NADPH oxidase activity and most likely ROS
production, since CYTD treatment fully restored the ability of
mDC from CGD patients to produce IL-1β. In contrast to this,
the small amounts of IL-1β induced by glucan-mp from healthy
donor mDC were completely absent when mDC from CGD
patients were tested suggesting an alternate mechanism of IL-1β
production that differs from sustained surface dectin-1 signaling.
Thus, the attenuated stimulation through dectin-1, which occurs
when small particle β-glucans are used requires the presence of
ROS for any IL-1β production. It has previously been shown that
both curdlan- and glucan-mp-induced IL-1β requires activation
of caspase-1 and caspase-8, to allow pro-IL-1β cleavage by the
inflammasome (11, 23). However, with regard to priming of the
IL-1β response, we clearly showed that glucan-mp resulted in
much lower levels of pro-IL-1β mRNA and protein expression.
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age- and sex-matched CGD patients (Royal Free Hospital,
London). Appropriate consent to use blood-derived cells for
research was obtained. Ethics Reference Number: 04/Q0501/119.

Given the critical role of IL-1β in antifungal immunity (3, 12, 16),
the regulation of its production as determined by β-glucan size
likely provides a key molecular checkpoint in eliciting appropriate
cytokine secretion from mDC in response to dectin-1 activation.
These findings give insights into the mechanisms DC utilize to
orchestrate an effective immune response to fungi. Phagocytosis
is an effective cellular mechanism for the removal of foreign
organisms; therefore, it may be advantageous for cells, which are
capable of phagocytosing fungi, thereby controlling the infection, to limit their production of inflammatory cytokines such as
IL-1β that might induce subsequent tissue damage. Pathogenic
fungal species such as C. albicans exist as both colonizing
yeast and invasive hyphae and structural differences exist in
β-glucans derived from these differing forms—hyphae exhibit a
cyclical β-glucan structure while yeast β-glucans are linear (17).
Importantly, β-glucan derived from hyphal C. albicans stimulates
significantly more IL-1β from DC compared to DC stimulated
with β-glucan from yeast (17). Likewise, it has been reported
that murine macrophages phagocytose hyphal C. albicans more
slowly than a strain of C. albicans, which is maintained in a yeast
form, and prevented from forming hyphae; under these circumstances, the macrophages exhibit frustrated phagocytosis (10).
Our data clearly showed that NADPH oxidase activity and
ROS were not required for IL-1β production when phagocytosis
was prevented. Previously, de Luca et al. also reported that ROS
were not required for induction of IL-1β by C. albicans or LPSprimed macrophages (21), but they did not state what form of
C. albicans was used in these experiments. Our data would be
consistent with their using hyphal C. albicans and hence induction of frustrated phagocytosis and induction of IL-1β independent of ROS.
There are significant in vivo implications of our findings.
Dectin-1-stimulated DC potently drive the differentiation
of naïve CD4+ T cells to TH1- and TH17-cells required for
protective antifungal immunity, and IL-1β, IL-6, and IL-23 are
important in generating these T cell subsets. Our data show that
naïve CD4+ T cells produce higher amounts of IL-17 and IFNγ
when stimulated in conditioned media derived from curdlanstimulated mDC compared to those stimulated with glucan-mp.
Therefore, when DC (or macrophages) are confronted with noninvasive yeast, they can clear the infection by rapid phagocytosis,
especially macrophages, and limited production of IL-1β, and
hence in the case of mDC, which respond to autocrine and
macrophage-derived IL-1β IL-6 and IL-23. Conversely, when
confronted with invasive hyphal fungi, phagocytosis will be
frustrated and an enhanced cytokine response produced with
elevated macrophage and mDC production of IL-1β and hence
elevated mDC production of IL-6 and IL-23. This in turn will
be a critical factor in the stimulation of the TH1 and TH17 adaptive immune responses needed to clear this more threatening
infection.

β-Glucan Isolation and Characterization

β-Glucan was isolated from S. cerevisiae using a modification of
the method of Williams et al. as described by Mueller and colleagues (29, 30). Specifically, phosphoric acid was used instead
of hydrochloric acid in the protic acid digestion step. This
approach results in a highly pure glucan, but with less degradation of the glucan polymer structure. The glucan was characterized by 1H-NMR as described by Lowman et al. (17). The
glucan (~20 mg) was dissolved in 700 µl of deuterated DMSOd6.
Approximately 50 µl of TFA was added to shift the water peak
away from the carbohydrate spectral region. The 1H-NMR spectra were obtained at 80°C. S. cerevisiae glucan was determined
to be >95% pure based on the 1D 1H-NMR and comparison to
an ultrapure (>97%) glucan reference standard produced in the
Williams laboratory.

Cell Isolation and Generation of mDCs

Human blood was sourced from healthy donors (Addenbrooke’s
Hospital, Cambridge) and age, sex-matched CGD patients
(Royal Free Hospital, London). Human mDCs were generated
from CD14+ monocytes isolated from PBMC by magnetic bead
separation (Miltenyi) and were differentiated by culturing for
6 days in RPMI1640 (Lonza) supplemented 5% FCS (Biosera),
20 ng/ml GM-CSF (Life Technologies) and 4 ng/ml IL-4 (BD
Biosciences) as described previously (23, 31, 32). Naïve human
CD4+ T cells were isolated by magnetic bead separation
(Miltenyi).

Stimulation of mDC

Monocyte-derived dendritic cells were stimulated with 50 µg/ml
of curdlan (Wako), curdlan microparticles (curdlan-mp) [generated as described previously (14)], and β-1,3 glucan microparticles (glucan-mp) [generated as described above (29, 30)]. mDCs
were also stimulated with β-glucans and 2 µM CYTD (Sigma)
and/or 10 ng/ml IL-1β (Miltenyi) simultaneously. Cell cultures
were incubated for predefined time periods as highlighted in
figure legends.

Differentiation of Naïve CD4+ T Cells

Naïve CD4+ T cells were stimulated with anti-CD3/anti-CD28
activation beads (1:1 ratio) (ThermoFisher) and 20 IU of IL-2
(Becton Dickinson) for 7 days in the presence of supernatants
derived from mDC prestimulated with either 50 µg/ml of curdlan
or glucan-mp. CD4+ T cell culture supernatants were subsequently
harvested to evaluate IL-17 and IFNγ secretion.

MATERIALS AND METHODS

Cytokine Analysis by Enzyme-Linked
Immunosorbent Assay (ELISA)

Ethics Statement

Human blood was sourced from apheresis cones derived from
healthy donors (Addenbrooke’s Hospital, Cambridge) and
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(eBioscience), TSLP, and CCL22 (R&D) according to the manufacturers’ instructions. Briefly, plates were precoated with capture
antibody overnight and washed five times with wash buffer composed of 1× PBS supplemented with 0.05% Tween 20 (Sigma). This
wash protocol was repeated between each protocol step. ELISA
plates were then blocked followed by addition of experimental
supernatants or standards. Plates were then treated with biotinylated detection antibodies followed by avidin-horseradish peroxidase. 3,3 ′,5,5′-tetramethylbenzidine substrate (eBioscience)
was added to each well, with the reaction developed for
10–15 min in the dark. ELISA plates were read at a wavelength
of 450 nm with cytokine concentrations calculated using the
standard curve values.

buffer composed of 1× TBS supplemented with 0.1% Tween 20
between each protocol step. Membranes were then probed with
primary antibodies to pro-IL-1β (R&D, AB-201-AB), HIF-1α
(Novus, NB100-449), and β-actin (Abcam) overnight, and then
incubated in HRP-conjugated secondary antibodies. Protein
was detected with ECL (PerkinElmer) and visualized using
GBox (Syngene). Protein expression was analyzed relative to
β-actin control.

Flow Cytometry

Flow cytometry was used to determine mDC activation status,
dectin-1 expression, and ROS production. For mDC activation
status and dectin-1 expression, mDC were resuspended in FACS
buffer consisting of PBS supplemented with 0.1% BSA, 2 mM
EDTA, and 0.01% Sodium Azide (All Sigma) after stimulation.
ROS were detected by incubating mDC with CellRox Green
(Thermo) fluorescence dye during stimulations as per manufacturer’s instructions; followed by harvesting into FACS buffer. mDC
were then treated with 10% mouse serum (Sigma) for 30 min on
ice to block non-specific binding of antibodies to Fc receptors.
mDCs were then stained for 30 min with anti-CD11c (Becton
Dickinson, Clone B-ly6), anti-CD86 (Biolegend Clone IT2.2), and
anti-HLA-DR (Becton Dickinson, Clone 946.6) to examine mDC
activation status and anti-dectin-1 (R&D Systems, Clone 259931)
to determine dectin-1 downregulation. Cells were then washed,
centrifuged at 300 g for 5 min, and re-suspended in FACS buffer for
analysis. mDC expression of CD11c, CD86, HLA-DR, dectin-1, and
ROS was determined by mean fluorescence intensity and acquired
using a flow cytometer (FACSFortessa, Becton Dickinson).

RNA Isolation and Quantitative Real-time
Polymerase Chain Reaction (qRT-PCR)

Total RNA was isolated using commercial RNAeasy kits
(Bioline) according to the manufacturer’s instructions. mDCs
were initially stimulated for 4, 8, or 12 h, supernatants were
removed, and cells lysed in lysis buffer. Briefly, lysates were
homogenized, placed into spin columns, washed, and centrifuged with commercial diluents and RNA was eluted from the
spin columns. qRT-PCR was carried out using TaqMan Gene
Expression Assays (Applied Biosystems) for IL-1β, IL-6, IL-23,
TSLP, and HPRT. RNA was added to master mix consisting
of commercial gene specific probe and primer sets (Applied
Biosystems), TaqMan® Universal PCR Master Mix, reverse
transcriptase and RNase free H2O. Taqman reactions were run
for 40 cycles on a predefined temperature cycling program.
Gene expression for cytokines were normalized to expression of
the house-keeping gene, HPRT, and calculated as either relative
expression (2−ΔCt) from unstimulated control cells.

Data Analysis

Cumulative data displayed as mean ± SEM. Data were analyzed
using the Prism statistical package (GraphPad) with statistical
analysis completed using one-way ANOVA with Bonferroni posttests (ns = not significant, ****p = 0.001,***p = 0.01, **p = 0.05,
*p = 0.1). Flow cytometry data were analyzed using FlowJo 10
software (Treestar).

Cell Lysis, Sodium Dodecyl Sulfate (SDS)Polyacrylamide Gel Electrophoresis
(PAGE), and Immunoblotting

Monocyte-derived dendritic cells were lysed in cytoplasmic
lysis buffer [10 mM HEPES, 50 mM NaCl, 0.5 M Sucrose,
0.1 mM EDTA, 0.5% v/v Triton X-100, 10 mM Tetrasodium
pyrophosphate, 17.5 mM β-glycerophosphate (all from Sigma)
and one complete mini protease inhibitor cocktail tablet
(Roche)]. Cellular lysates were scraped, and frozen at −20°C
overnight before thawing to aid cell lysis. Lysates were centrifuged at 16,000 g at 4°C and the cytoplasmic supernatant was
separated from the nuclear pellet. Total protein was quantified
by Bradford Assay (Thermo). SDS-PAGE was used to resolve
proteins. Equivalent concentrations of protein lysate were
mixed with 6× loading buffer (10% w/v SDS, 0.3 M Tris–HCl,
25% v/v β-Mercaptoethanol) and glycerol (all from Sigma) and
boiled for 10 min. Samples and molecular weight reference
proteins were loaded on to precast gradient (4–20%) acrylamide
gels (BioRad) and run for 90 min at constant amps (30 mA).
Resolved proteins were detected after transfer to nitrocellulose membranes by immunoblot. Membranes were blocked
in 5% milk (w/v) (Marvel) and washed three times with wash
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